NDT Advance Access originally published online on September 7, 2004
Nephrology Dialysis Transplantation 2004 19(11):2713-2720; doi:10.1093/ndt/gfh423
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrol Dial Transplant Vol. 19 No. 11 © ERA-EDTA 2004; all rights reserved
Original Article
Suppressed T-cell activation by IFN-
-induced expression of PD-L1 on renal tubular epithelial cells
1 Division of Nephrology, Kantonsspital St Gallen, Switzerland, 2 Institute of Anatomy, University of Zürich, Switzerland and 3 Department of Nephrology, TU-Klinikum rechts der Isar, Munich, Germany
Correspondence and offprint requests to: Prof. Dr R. P. Wüthrich, Renal Division, University Hospital, Rämistrasse 100, 8091 Zürich, Switzerland. Email: rudolf.wuethrich{at}usz.ch The authors wish it to be known that, in their opinion, the first two authors contributed equally to this work
Background. The interaction of the T-cell molecule PD-1 (programmed death-1) with its ligands PD-L1 and PD-L2 represents a known mechanism of T-cell inhibition. PD-1 is homologous to CD28 while the PD-1 ligands share homology with the B7 family of co-stimulatory molecules.
Methods. We have studied surface expression and transcript levels of PD-L1 and PD-L2 on murine renal tubular epithelial cells (TEC) by flow cytometric analysis and reverse transcriptionpolymerase chain reaction. Western blot analysis was used to confirm protein expression of PD-L1. We also tested the functional role of PD-L1 and PD-1 in antigen presentation. Furthermore, we stained mouse kidney transplants with rejection for the expression of the PD-1 ligands.
Results. We found that PD-L1 but not PD-L2 was weakly expressed on unstimulated TEC. Upon stimulation with IFN-
, a dose-dependent upregulation of PD-L1 expression was observed. Blockade of the PD-L1/PD-1 pathway with monoclonal antibodies in antigen presentation assays uncovered an inhibitory role of this ligand system in Th1 and Th2 cell activation. Staining for PD-L1 was strong in proximal and distal tubules in mouse kidney transplants with rejection, whereas staining of normal kidneys and syngenic mouse kidney transplants did not reveal PD-L1 expression. PD-L2 was not observed in normal or rejected mouse kidneys.
Conclusions. These data demonstrate that PD-L1 is an inducible renal tubular epithelial antigen that negatively regulates T-cell responses elicited by IFN-
-stimulated TEC. We speculate that the PD-1/PD-L1 pathway may play a role in protecting the epithelium from immune-mediated tubulointerstitial injury.
Keywords: antigen presentation; co-stimulation; PD-1; PD-L1; PD-L2; renal tubular epithelial cells
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. L. Edgtton, J. Y. Kausman, M. Li, K. O'Sullivan, C. Lo, P. Hutchinson, H. Yagita, S. R. Holdsworth, and A. R. Kitching Intrarenal Antigens Activate CD4+ Cells via Co-stimulatory Signals from Dendritic Cells J. Am. Soc. Nephrol., March 1, 2008; 19(3): 515 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, J. Popoola, S. Khandwala, N. Vadivel, V. Vanguri, X. Yuan, S. Dada, I. Guleria, C. Tian, M. J. Ansari, et al. Critical Role of Donor Tissue Expression of Programmed Death Ligand-1 in Regulating Cardiac Allograft Rejection and Vasculopathy Circulation, February 5, 2008; 117(5): 660 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Menke, J. A. Lucas, G. C. Zeller, M. E. Keir, X. R. Huang, N. Tsuboi, T. N. Mayadas, H. Y. Lan, A. H. Sharpe, and V. R. Kelley Programmed Death 1 Ligand (PD-L) 1 and PD-L2 Limit Autoimmune Kidney Disease: Distinct Roles J. Immunol., December 1, 2007; 179(11): 7466 - 7477. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Waeckerle-Men, A. Starke, and R. P. Wuthrich PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+cytotoxic T cells Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1527 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Keir, S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, and A. H. Sharpe Tissue expression of PD-L1 mediates peripheral T cell tolerance J. Exp. Med., April 17, 2006; 203(4): 883 - 895. [Abstract] [Full Text] [PDF] |
||||




